Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy–A meta-analysis

By Sher Amna   Wu Shenhong  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite

Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma

By Terheyden Patrick   Hofmann Maja   Weininger M.   Bröcker Eva-B.   Becker Jürgen  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 11, 2007-11 ,pp. : 897-901

Springer Publishing Company

Access to resources Recommend Favorite

Anti-vascular endothelial growth factor antibody single therapy for pancreatic neuroendocrine carcinoma exhibits a marked tumor growth-inhibitory effect

By Kasuya Kazuhiko   Nagakawa Yuichi   Suzuki Minako   Tanaka Hiroaki   Ohta Hiroshi   Itoi Takao   Tsuchida Akihiko  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-11 ,pp. : 1047-1052

Spandidos Publications

Access to resources Recommend Favorite

Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model

By Jung Y.D.   Mansfield P.F.   Akagi M.   Takeda A.   Liu W.   Bucana C.D.   Hicklin D.J.   Ellis L.M.  

European Journal of Cancer, Vol. 38, Iss. 8, 2002-05 ,pp. : 1133-1140

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of c-erbB-2 and Vascular Endothelial Growth Factor in Colorectal Liver Metastases

By Chen Jinggui  

Annals of Surgical Oncology, Vol. 17, Iss. 6, 2010-06 ,pp. : 1555-1563

Springer Publishing Company

Access to resources Recommend Favorite